A Phase II randomized, double-blind, placebo controlled

Project: Research project

Project Details

Description

A Phase II randomized, double-blind, placebo controlled study to assess safety, toerability and effect on tumor size of MCS110 in patients with pigmented villonodular synovitis (PVNS)
StatusFinished
Effective start/end date11/1/114/30/19

Funding

  • Novartis Pharma AG

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.